https://www.selleckchem.com/products/gw0742.html
Three patients developed pulmonary congestion (21.4%), and all patients stabilized within 24 h. Active rehabilitation during ECMO was possible in all patients, and the median duration of awake state during ECMO was 14 days. A total of 10 patients were bridged successfully to lung transplantation, and hospital survival rates were 90%. OxyRVAD stabilized hemodynamic parameters without fatal complications, permitted the discontinuation of sedation, and allowed active rehabilitation in patients with severe right heart failure. OxyRVAD may be
Like
Comment
Share
